Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)

NCT02671968 is registered in ClinicalTrials.gov with Science Consulting in Diabetes as lead sponsor.

NCT NCT02671968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02671968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)
Lead sponsor
Science Consulting in Diabetes
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
October 24, 2017
Enrollment
141 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes